
    
      The purpose of this study is to evaluate the therapeutic equivalence and safety of Tazarotene
      Cream 0.1% and TazoracÂ® (tazarotene cream 0.1%) in the treatment of acne vulgaris and to
      demonstrate the superiority of the test and reference products over the placebo control.
    
  